Back to Journals » Journal of Vascular Diagnostics and Interventions » Volume 6

Ultrasound-guided percutaneous thrombin injection following iatrogenic femoral artery pseudoaneurysm: patient selection and perspectives

Authors Sizemore G, Ayubi F, Clark B, Kellicut D

Received 26 September 2017

Accepted for publication 10 January 2018

Published 7 August 2018 Volume 2018:6 Pages 1—5

DOI https://doi.org/10.2147/JVD.S127255

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Dr Deipolyi


Grant Sizemore,1 Farhan Ayubi,2 Benjamin Clark,1 Dwight Kellicut2

1General Surgery, Tripler Army Medical Center, Honolulu, HI, USA; 2Vascular Surgery, Tripler Army Medical Center, Honolulu, HI, USA

Abstract: Ultrasound-guided percutaneous thrombin injection (UGTI) following iatrogenic femoral artery pseudoaneurysms has been the standard of care as first-line treatment at many institutions since its initial description by Liau et al in 1997. UGTI underwent rapid adoption given its significant advantages to patients including shorter procedure times, decreased discomfort, lower rates of recurrence, and the avoidance of surgical intervention in appropriate cases. Despite the availability of less-invasive approaches, through numerous head-to-head studies, UGTI has demonstrated clear benefit over ultrasound-guided compression in the treatment of iatrogenic femoral artery pseudoaneurysms. Although newer interventions such as percutaneous coil embolization have attracted attention for their superior ability to manage those patients with high-level anticoagulation or allergies to thrombin, at this time they do not provide an equal alternative to thrombin injection. In this review, we focus on issues related to the selection of patients who benefit from UGTI for the treatment of iatrogenic pseudoaneurysms.

Keywords: false aneurysm, endovascular complication, cardiac catheterization, interventional radiology, autologous thrombin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]